Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 22, 2021

SELL
$134.22 - $202.37 $14,361 - $21,653
-107 Closed
0 $0
Q1 2021

Apr 12, 2021

SELL
$140.25 - $196.86 $561 - $787
-4 Reduced 3.6%
107 $19,000
Q4 2020

Feb 11, 2021

BUY
$126.47 - $163.7 $2,782 - $3,601
22 Added 24.72%
111 $16,000
Q3 2020

Oct 28, 2020

SELL
$87.44 - $125.0 $34,976 - $50,000
-400 Reduced 81.8%
89 $11,000
Q2 2020

Jul 20, 2020

BUY
$58.39 - $89.31 $13,955 - $21,345
239 Added 95.6%
489 $44,000
Q3 2019

Oct 15, 2019

BUY
$49.99 - $62.0 $12,497 - $15,500
250 New
250 $13,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.5B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Valeo Financial Advisors, LLC Portfolio

Follow Valeo Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Valeo Financial Advisors, LLC with notifications on news.